{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:42:24Z","timestamp":1779345744118,"version":"3.51.4"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007103","name":"Research center of physiology, Semnan University of medical sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.lfs.2019.116950","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T11:05:31Z","timestamp":1570619131000},"page":"116950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["The effect of C-peptide on diabetic nephropathy: A review of molecular mechanisms"],"prefix":"10.1016","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1706-6212","authenticated-orcid":false,"given":"Habib","family":"Yaribeygi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.lfs.2019.116950_bib1","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/dme.12716","article-title":"Prevalence and incidence of diabetes mellitus: a nationwide population\u2010based pharmaco\u2010epidemiological study in Sweden","volume":"32","author":"Jansson","year":"2015","journal-title":"Diabet. Med."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010210","article-title":"Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study","volume":"6","author":"Sharma","year":"2016","journal-title":"BMJ open"},{"issue":"15","key":"10.1016\/j.lfs.2019.116950_bib3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012","volume":"376","author":"Mayer-Davis","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.lfs.2019.116950_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and macrovascular complications of diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clin. Diabetes"},{"issue":"10","key":"10.1016\/j.lfs.2019.116950_bib6","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrendo.2016.105","article-title":"Diabetes mellitus statistics on prevalence and mortality: facts and fallacies","volume":"12","author":"Zimmet","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.lfs.2019.116950_bib7","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/jcb.27475","article-title":"Potential roles of microRNAs in redox state: an update","volume":"120","author":"Yaribeygi","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.lfs.2019.116950_bib8","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/ggi.13534","article-title":"Diabetic nephropathy is associated with frailty in patients with chronic hemodialysis","volume":"18","author":"Kakio","year":"2018","journal-title":"Geriatr. Gerontol. Int."},{"issue":"7","key":"10.1016\/j.lfs.2019.116950_bib9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/dom.12630","article-title":"Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?","volume":"18","author":"Gallagher","year":"2016","journal-title":"Diabetes Obes. Metab."},{"issue":"3","key":"10.1016\/j.lfs.2019.116950_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.diabres.2015.01.016","article-title":"C-peptide: new findings and therapeutic possibilities","volume":"107","author":"Wahren","year":"2015","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"3","key":"10.1016\/j.lfs.2019.116950_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/db15-1264","article-title":"Monitoring C-peptide storage and secretion in islet \u03b2-cells in vitro and in vivo","volume":"65","author":"Zhu","year":"2016","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.lfs.2019.116950_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13300-017-0265-4","article-title":"A practical review of C-peptide testing in diabetes","volume":"8","author":"Leighton","year":"2017","journal-title":"Diabetes Ther."},{"issue":"9","key":"10.1016\/j.lfs.2019.116950_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jdiacomp.2019.05.019","article-title":"Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration","volume":"33","author":"Williams","year":"2019","journal-title":"J. Diabetes Complicat."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/joim.12548","article-title":"C\u2010peptide and diabetic kidney disease","volume":"281","author":"Brunskill","year":"2017","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.lfs.2019.116950_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1681\/ASN.2016020237","article-title":"Suppressor of cytokine signaling-1 peptidomimetic limits progression of diabetic nephropathy","volume":"28","author":"Recio","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"Supplement 1","key":"10.1016\/j.lfs.2019.116950_bib16","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"Association","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2019.116950_bib17","series-title":"Diabetes","first-page":"12","article-title":"Classification of diabetes","author":"de Faria Maraschin","year":"2013"},{"issue":"2","key":"10.1016\/j.lfs.2019.116950_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/pedi.12135","article-title":"Residual C\u2010peptide in type 1 diabetes: what do we really know?","volume":"15","author":"VanBuecken","year":"2014","journal-title":"Pediatr. Diabetes"},{"issue":"7","key":"10.1016\/j.lfs.2019.116950_bib19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/dme.12159","article-title":"The clinical utility of C\u2010peptide measurement in the care of patients with diabetes","volume":"30","author":"Jones","year":"2013","journal-title":"Diabet. Med."},{"issue":"7","key":"10.1016\/j.lfs.2019.116950_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/CS20080441","article-title":"Cellular and physiological effects of C-peptide","volume":"116","author":"Hills","year":"2009","journal-title":"Clin. Sci."},{"key":"10.1016\/j.lfs.2019.116950_bib21","series-title":"StatPearls [Internet]","article-title":"C peptide","author":"Venugopal","year":"2018"},{"issue":"4","key":"10.1016\/j.lfs.2019.116950_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physiol.00008.2015","article-title":"The physiology of proinsulin C-peptide: unanswered questions and a proposed model","volume":"30","author":"Yosten","year":"2015","journal-title":"Physiology"},{"issue":"23","key":"10.1016\/j.lfs.2019.116950_bib23","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1073\/pnas.96.23.13318","article-title":"Specific binding of proinsulin C-peptide to human cell membranes","volume":"96","author":"Rigler","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2019.116950_bib24","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1096\/fj.201700891R","article-title":"C-peptide prevents NF-\u03baB from recruiting p300 and binding to the inos promoter in diabetic nephropathy","volume":"32","author":"Li","year":"2018","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.lfs.2019.116950_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028294","article-title":"C-peptide increases Na, K-ATPase expression via PKC-and MAP kinase-dependent activation of transcription factor ZEB in human renal tubular cells","volume":"6","author":"Galuska","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lfs.2019.116950_bib26","doi-asserted-by":"crossref","first-page":"E759","DOI":"10.1152\/ajpendo.2000.278.5.E759","article-title":"Role of C-peptide in human physiology","volume":"278","author":"Wahren","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3071","article-title":"The dual effect of C\u2010peptide on cellular activation and atherosclerosis: protective or not?","volume":"35","author":"Alves","year":"2019","journal-title":"Diabetes Metabol. Res. Rev."},{"issue":"6","key":"10.1016\/j.lfs.2019.116950_bib28","article-title":"C-peptide is independently associated with an increased risk of coronary artery disease in T2DM subjects: a cross-sectional study","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.lfs.2019.116950_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0026-0495(90)90297-P","article-title":"Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels","volume":"39","author":"Seidell","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/j.lfs.2019.116950_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.archger.2017.05.018","article-title":"Serum C-peptide as a key contributor to lipid-related residual cardiovascular risk in the elderly","volume":"73","author":"Li","year":"2017","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib31","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1038\/s41598-017-05785-0","article-title":"Obesity, adipokines, and C-peptide are associated with distinct plasma phospholipid profiles in adult males, an untargeted lipidomic approach","volume":"7","author":"Pickens","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.lfs.2019.116950_bib32","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/jcb.26450","article-title":"Oxidative stress induces renal failure: a review of possible molecular pathways","volume":"119","author":"Yaribeygi","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2019.116950_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2016.08.022","article-title":"Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update","volume":"791","author":"Bhattacharjee","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2019.116950_bib34","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.diabres.2008.09.042","article-title":"Diabetic nephropathy: important pathophysiologic mechanisms","volume":"82","author":"Soldatos","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"10.1016\/j.lfs.2019.116950_bib35","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","article-title":"Update on diabetic nephropathy: core curriculum 2018","volume":"71","author":"Umanath","year":"2018","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.lfs.2019.116950_bib36","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1002\/jcp.27427","article-title":"Interleukin\u201018 and diabetic nephropathy: a review","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.lfs.2019.116950_bib37","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1002\/jcb.27055","article-title":"Fenofibrate improves renal function by amelioration of NOX\u20104, IL\u201018, and p53 expression in an experimental model of diabetic nephropathy","volume":"119","author":"Yaribeygi","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.lfs.2019.116950_bib38","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1002\/jcb.26806","article-title":"Crocin improves renal function by declining Nox\u20104, IL\u201018, and p53 expression levels in an experimental model of diabetic nephropathy","volume":"119","author":"Yaribeygi","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.lfs.2019.116950_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.vph.2013.01.001","article-title":"Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update","volume":"58","author":"Arora","year":"2013","journal-title":"Vasc. Pharmacol."},{"issue":"8","key":"10.1016\/j.lfs.2019.116950_bib40","doi-asserted-by":"crossref","first-page":"F689","DOI":"10.1152\/ajprenal.00502.2015","article-title":"Transforming growth factor-\u03b21 and diabetic nephropathy","volume":"310","author":"Chang","year":"2015","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2019.116950_bib41","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s10753-016-0413-4","article-title":"Diosmin modulates the NF-kB signal transduction pathways and downregulation of various oxidative stress markers in alloxan-induced diabetic nephropathy","volume":"39","author":"Ahmed","year":"2016","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.lfs.2019.116950_bib42","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1172\/JCI72271","article-title":"Molecular mechanisms of diabetic kidney disease","volume":"124","author":"Reidy","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lfs.2019.116950_bib43","series-title":"Effects of Novel Antidiabetes Agents on Apoptotic Processes in Diabetes and Malignancy: Implications for Lowering Tissue Damage","author":"Yaribeygi","year":"2019"},{"key":"10.1016\/j.lfs.2019.116950_bib44","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2337\/diacare.27.2007.S79","article-title":"Nephropathy in diabetes","volume":"27","author":"Molitch","year":"2004","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.lfs.2019.116950_bib45","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00125-004-1404-9","article-title":"Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells","volume":"47","author":"Al-Rasheed","year":"2004","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00125-004-1602-5","article-title":"C-peptide stimulates ERK1\/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells","volume":"48","author":"Zhong","year":"2005","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/dmrr.2359","article-title":"C\u2010peptide\u2010stimulated nitric oxide production in a cultured pulmonary artery endothelium is erythrocyte mediated and requires Zn2+","volume":"29","author":"Giebink","year":"2013","journal-title":"Diabetes Metabol. Res. Rev."},{"issue":"3","key":"10.1016\/j.lfs.2019.116950_bib48","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1900\/RDS.2009.6.138","article-title":"C-peptide and its intracellular signaling","volume":"6","author":"Hills","year":"2009","journal-title":"Rev. Diabet. Stud.: Reg. Dev. Stud."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/187152211794519403","article-title":"Anti-inflammatory effects of C-peptide prevent endothelial dysfunction in type 1 diabetes. Immunology, endocrine & metabolic agents in medicinal chemistry (formerly current medicinal chemistry-immunology","volume":"11","author":"Cifarelli","year":"2011","journal-title":"Endocr. Metab. Agents"},{"issue":"48","key":"10.1016\/j.lfs.2019.116950_bib50","doi-asserted-by":"crossref","first-page":"49747","DOI":"10.1074\/jbc.M408268200","article-title":"Ligand-independent activation of peroxisome proliferator-activated receptor-\u03b3 by insulin and C-peptide in kidney proximal tubular cells dependent on phosphatidylinositol 3-kinase activity","volume":"279","author":"Al-Rasheed","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00210-001-0502-1","article-title":"Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study","volume":"365","author":"Huang","year":"2002","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2019.116950_bib52","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/ndt\/gfh163","article-title":"C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats","volume":"19","author":"Samneg\u00e5rd","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2019.116950_bib53","series-title":"Oxygen Transport to Tissue Xxx","first-page":"219","article-title":"C-peptide normalizes glomerular filtration rate in hyperfiltrating conscious diabetic rats","author":"Stridh","year":"2009"},{"key":"10.1016\/j.lfs.2019.116950_bib54","article-title":"Proinflammatory effects of C-Peptide in different tissues","volume":"2012","author":"Vasic","year":"2012","journal-title":"Int. J. Inflamm."},{"issue":"3","key":"10.1016\/j.lfs.2019.116950_bib55","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/ndt\/gfh683","article-title":"C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats","volume":"20","author":"Samneg\u00e5rd","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.lfs.2019.116950_bib56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000289864","article-title":"C-peptide as a therapeutic tool in diabetic nephropathy","volume":"31","author":"Hills","year":"2010","journal-title":"Am. J. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2019.116950_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127439","article-title":"C-peptide as a therapy for kidney disease: a systematic review and meta-analysis","volume":"10","author":"Shaw","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2019.116950_bib58","series-title":"Anti-inflammatory Properties of C-Peptide. A New Therapeutic Strategy for Reducing Vascular Damage in Type 1 Diabetes Patients","author":"Cifarelli","year":"2011"},{"issue":"2","key":"10.1016\/j.lfs.2019.116950_bib59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/dc08-1241","article-title":"Fasting plasma C-peptide and micro-and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients","volume":"32","author":"Panero","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2019.116950_bib60","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3389\/fphar.2017.00798","article-title":"NF-\u03ba\u03b2: a potential target in the management of vascular complications of diabetes","volume":"8","author":"Suryavanshi","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.lfs.2019.116950_bib61","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/ndt\/gfh207","article-title":"NF-\u03baB activation and overexpression of regulated genes in human diabetic nephropathy","volume":"19","author":"Mezzano","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib62","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.redox.2013.07.005","article-title":"Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-\u03baB pathways in diabetic neuropathy","volume":"1","author":"Yerra","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2019.116950_bib63","first-page":"11","article-title":"Transcription factors in the pathogenesis of diabetic nephropathy","author":"Sanchez","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2019.116950_bib64","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.atherosclerosis.2007.12.060","article-title":"Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-\u03baB activation in vascular smooth muscle cells","volume":"201","author":"Cifarelli","year":"2008","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.lfs.2019.116950_bib65","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1681\/ASN.2005080797","article-title":"C-peptide signals via g\u03b1i to protect against TNF-\u03b1\u2013mediated apoptosis of opossum kidney proximal tubular cells","volume":"17","author":"Al-Rasheed","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.lfs.2019.116950_bib66","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s00125-008-1032-x","article-title":"Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-\u03baB pathway","volume":"51","author":"Luppi","year":"2008","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.lfs.2019.116950_bib67","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2337\/db11-1423","article-title":"The clinical potential of C-peptide replacement in type 1 diabetes","volume":"61","author":"Wahren","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2019.116950_bib68","series-title":"Seminars in Nephrology","article-title":"Histopathology of diabetic nephropathy","author":"Fioretto","year":"2007"},{"issue":"2","key":"10.1016\/j.lfs.2019.116950_bib69","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cvr\/cvu211","article-title":"C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy","volume":"104","author":"Bhatt","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.lfs.2019.116950_bib70","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/15604280214936","article-title":"C-peptide prevents hippocampal apoptosis in type 1 diabetes","volume":"3","author":"Li","year":"2002","journal-title":"Exp. Diabetes Res."},{"issue":"5","key":"10.1016\/j.lfs.2019.116950_bib71","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2337\/diabetes.54.5.1497","article-title":"The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats","volume":"54","author":"Sima","year":"2005","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.lfs.2019.116950_bib72","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1007\/s00125-011-2251-0","article-title":"C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD (P) H-oxidase reactive oxygen species generation in human aortic endothelial cells","volume":"54","author":"Cifarelli","year":"2011","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2337\/db12-0293","article-title":"C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species\u2013mediated transglutaminase 2 activation","volume":"62","author":"Bhatt","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2019.116950_bib74","series-title":"Mechanisms of Vascular Defects in Diabetes Mellitus","author":"Kartha","year":"2017"},{"key":"10.1016\/j.lfs.2019.116950_bib75","series-title":"Mechanisms of Vascular Defects in Diabetes Mellitus","first-page":"73","article-title":"Vascular remodeling in diabetes mellitus","author":"Vallurupalli","year":"2017"},{"issue":"6","key":"10.1016\/j.lfs.2019.116950_bib76","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.numecd.2019.03.002","article-title":"MicroRNA-24 attenuates vascular remodeling in diabetic rats through PI3K\/Akt signaling pathway","volume":"29","author":"Cai","year":"2019","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"2","key":"10.1016\/j.lfs.2019.116950_bib77","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00402543","article-title":"The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients","volume":"35","author":"Johansson","year":"1992","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.lfs.2019.116950_bib78","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.2337\/diabetes.51.10.3077","article-title":"C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes","volume":"51","author":"Hansen","year":"2002","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.lfs.2019.116950_bib79","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.niox.2003.08.004","article-title":"Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide","volume":"9","author":"Wallerath","year":"2003","journal-title":"Nitric Oxide"},{"issue":"12","key":"10.1016\/j.lfs.2019.116950_bib80","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00125-003-1232-3","article-title":"Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats","volume":"46","author":"Kitamura","year":"2003","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.lfs.2019.116950_bib81","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/cs0980283","article-title":"Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+, K+-ATPase activity in diabetes mellitus type I","volume":"98","author":"Forst","year":"2000","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib82","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00125-007-0853-3","article-title":"Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter","volume":"51","author":"Meyer","year":"2008","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.lfs.2019.116950_bib83","doi-asserted-by":"crossref","first-page":"E864","DOI":"10.1152\/ajpendo.00001.2003","article-title":"C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism","volume":"285","author":"Johansson","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"issue":"11","key":"10.1016\/j.lfs.2019.116950_bib84","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.2337\/db13-0039","article-title":"C-peptide activates AMPK\u03b1 and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes","volume":"62","author":"Bhatt","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib85","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/JOE-16-0349","article-title":"C-peptide protects against hyperglycemic memory and vascular endothelial cell apoptosis","volume":"231","author":"Bhatt","year":"2016","journal-title":"J. Endocrinol."},{"issue":"4","key":"10.1016\/j.lfs.2019.116950_bib86","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/dmrr.810","article-title":"Proinsulin C\u2010peptide abrogates type\u20101 diabetes\u2010induced increase of renal endothelial nitric oxide synthase in rats","volume":"24","author":"Kamikawa","year":"2008","journal-title":"Diabetes Metabol. Res. Rev."},{"issue":"6","key":"10.1016\/j.lfs.2019.116950_bib87","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1139\/apnm-2017-0617","article-title":"Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide","volume":"43","author":"Elbassuoni","year":"2018","journal-title":"Appl. Physiol. Nutr. Metabol."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib88","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1681\/ASN.2010111210","article-title":"Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy","volume":"23","author":"Lin","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2019.116950_bib89","series-title":"Linking Metabolism and Immunology: Diabetic Nephropathy Is an Inflammatory Disease","author":"Tuttle","year":"2005"},{"issue":"6","key":"10.1016\/j.lfs.2019.116950_bib90","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneph.2011.51","article-title":"Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy","volume":"7","author":"Navarro-Gonz\u00e1lez","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2019.116950_bib91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/CS20120198","article-title":"Inflammation and the pathogenesis of diabetic nephropathy","volume":"124","author":"Wada","year":"2013","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib92","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1755-5922.2010.00218.x","article-title":"Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy","volume":"30","author":"Elmarakby","year":"2012","journal-title":"Cardiovasc. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2019.116950_bib93","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2337\/diab.42.3.450","article-title":"mRNA expression of growth factors in glomeruli from diabetic rats","volume":"42","author":"Nakamura","year":"1993","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.lfs.2019.116950_bib94","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s001250051241","article-title":"Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-\u03b1 and inducible nitric oxide synthase in diabetic rat glomeruli","volume":"42","author":"Sugimoto","year":"1999","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.lfs.2019.116950_bib95","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1681\/ASN.2007091048","article-title":"The role of inflammatory cytokines in diabetic nephropathy","volume":"19","author":"Navarro-Gonzalez","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2019.116950_bib96","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1900\/RDS.2009.6.168","article-title":"Anti-inflammatory properties of C-peptide","volume":"6","author":"Haidet","year":"2009","journal-title":"Rev. Diabet. Stud.: Reg. Dev. Stud."},{"issue":"14","key":"10.1016\/j.lfs.2019.116950_bib97","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1096\/fj.00-0183com","article-title":"C-peptide inhibits leukocyte\u2013endothelium interaction in the microcirculation during acute endothelial dysfunction","volume":"14","author":"SCALIA","year":"2000","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib98","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00011-011-0384-8","article-title":"C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia","volume":"61","author":"Haidet","year":"2012","journal-title":"Inflamm. Res."},{"issue":"11","key":"10.1016\/j.lfs.2019.116950_bib99","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s00125-005-1942-9","article-title":"Human proinsulin C-peptide prevents proliferation of rat aortic smooth muscle cells cultured in high-glucose conditions","volume":"48","author":"Kobayashi","year":"2005","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.lfs.2019.116950_bib100","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc16-2121","article-title":"Increased interleukin-35 levels in patients with type 1 diabetes with remaining C-peptide","volume":"40","author":"Espes","year":"2017","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/0971-4065.62093","article-title":"Serum C peptide level and renal function in diabetes mellitus","volume":"20","author":"Chowta","year":"2010","journal-title":"Indian J. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2019.116950_bib102","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/2046-4053-3-43","article-title":"The therapeutic potential of C-peptide in kidney disease: a protocol for a systematic review and meta-analysis","volume":"3","author":"Shaw","year":"2014","journal-title":"Syst. Rev."},{"issue":"5","key":"10.1016\/j.lfs.2019.116950_bib103","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/SHK.0b013e31820b2e98","article-title":"C-peptide ameliorates kidney injury following hemorrhagic shock","volume":"35","author":"Chima","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.lfs.2019.116950_bib104","series-title":"C-peptide: a New Mediator of Atherosclerosis in Diabetes","author":"Vasic","year":"2012"},{"key":"10.1016\/j.lfs.2019.116950_bib105","series-title":"C\u2010peptide Is Associated with NAFLD Inflammatory and Fibrotic Progression in Type 2 Diabetes","author":"Wang","year":"2019"},{"key":"10.1016\/j.lfs.2019.116950_bib106","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"issue":"4","key":"10.1016\/j.lfs.2019.116950_bib107","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jdiacomp.2015.12.018","article-title":"Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications","volume":"30","author":"Domingueti","year":"2016","journal-title":"J. Diabetes Complicat."},{"issue":"7","key":"10.1016\/j.lfs.2019.116950_bib108","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1002\/jcp.27808","article-title":"Protective effects of either C\u2010peptide or l\u2010arginine on pancreatic \u03b2\u2010cell function, proliferation, and oxidative stress in streptozotocin\u2010induced diabetic rats","volume":"234","author":"Ragy","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.lfs.2019.116950_bib109","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/dmrr.2528","article-title":"Autocrine C\u2010peptide mechanism underlying INS1 beta cell adaptation to oxidative stress","volume":"30","author":"Luppi","year":"2014","journal-title":"Diabetes Metabol. Res. Rev."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051930877X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051930877X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:25:24Z","timestamp":1758399924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432051930877X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":109,"alternative-id":["S002432051930877X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116950","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of C-peptide on diabetic nephropathy: A review of molecular mechanisms","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116950"}}